IBS and Crohn's: Which Packaged Foods Trigger Flares?

Irritable bowel syndrome (IBS) — characterised by recurrent abdominal pain associated with changes in stool frequency or form, in the absence of structural gut disease — is one of the most common functional gastrointestinal disorders globally. Indian epidemiological studies estimate IBS prevalence at 10–14% of the adult population — approximately 130–180 million people. Despite this prevalence, IBS is significantly underdiagnosed in India, where gastrointestinal symptoms are often normalised, attributed to food habits, or treated symptomatically without formal diagnosis.

Inflammatory bowel disease (IBD) — encompassing Crohn's disease and ulcerative colitis — was historically considered rare in India. This is no longer true. A 2023 meta-analysis reported a rapid increase in IBD incidence across India, with urbanisation, dietary Westernisation, and changes in the gut microbiome all identified as contributing factors. The prevalence of ulcerative colitis in India is estimated at approximately 44 per 100,000 population, with Crohn's disease at approximately 5 per 100,000 — still lower than in Western countries but accelerating rapidly.

Both IBS and IBD are profoundly affected by diet. For patients with these conditions, specific packaged food ingredients can trigger symptom flares or worsen intestinal inflammation — making knowledge of ingredient-risk interactions critically important.

Emulsifiers — food additives used to blend immiscible ingredients (oil and water) in packaged food — have emerged as a significant concern for IBS and IBD based on compelling experimental evidence. The gut epithelial barrier, a single-cell-thick layer separating the gut lumen from the bloodstream and immune system, is protected by a mucus layer produced by goblet cells. Research has shown that certain emulsifiers reduce the thickness and protective capacity of this mucus layer, allowing gut bacteria to come into closer contact with epithelial cells and potentially triggering or worsening intestinal inflammation.

The most extensively studied emulsifiers in this context: Carboxymethylcellulose (CMC, INS 466): A 2021 landmark study in the journal Nature found that CMC consumption in mice (at doses proportional to typical human dietary exposure) significantly altered gut microbiome composition, reduced mucus layer integrity, and caused mild intestinal inflammation. A subsequent 2022 human randomised crossover trial found that CMC consumption altered gut microbiome and mucus layer in some human volunteers. CMC is widely used in India in ice cream, packaged dairy desserts, bakery products, and sauces. Polysorbate 80 (PS-80, INS 433): The same research group found similar effects from polysorbate 80. Used in ice cream, salad dressings, and some baked goods in India. Carrageenan (INS 407): A seaweed-derived emulsifier used extensively in Indian dairy products (packaged milk to prevent separation, chocolate milk, flavoured dairy). Multiple animal studies show pro-inflammatory effects in the gut — particularly relevant for IBD patients. Lecithin (INS 322) and modified lecithin: Generally considered safer than the above — soy lecithin at typical use levels has not shown the same gut barrier disruption effects.

A summary of the emulsifiers discussed above and where they appear in Indian packaged food:

The low-FODMAP diet — restricting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols — is the most evidence-based dietary intervention for IBS, reducing symptoms in approximately 60–70% of IBS patients in randomised controlled trials. For Indian IBS patients, navigating FODMAP content in packaged foods requires understanding which common Indian packaged food ingredients are high FODMAP:

High-FODMAP sweeteners in packaged foods: Fructose (in excess of glucose — found in packaged apple juice, high-fructose corn syrup products, mango and pear juice). Sorbitol (INS 420) and mannitol (INS 421) — sugar alcohols used in sugar-free products. Lactose in packaged dairy products (significant for those with IBS-lactose sensitivity). High-FODMAP vegetables and fruits used in packaged products: Onion, garlic, and onion powder are extremely high FODMAP and are used in virtually every Indian packaged masala, seasoning mix, instant noodle masala, and ready-to-eat curry. This is one of the most significant packaged food FODMAP issues for Indian IBS patients — nearly all savoury packaged Indian foods contain onion and garlic. Wheat-based products: Wheat contains fructans — a major FODMAP for IBS patients. Most packaged biscuits, noodles, bread, and snacks use maida (wheat flour). Legume-based products: Packaged dal, bean-based snacks, and chickpea flour (besan) products — all high FODMAP in large amounts.

Artificial sweeteners in packaged 'sugar-free' and 'diet' products are a specific concern for IBS patients. Several sweeteners are poorly absorbed in the small intestine and are fermented by gut bacteria — exactly the mechanism that drives IBS symptoms:

Sorbitol (INS 420) and Mannitol (INS 421): These sugar alcohols are high FODMAP. They are used in sugar-free chewing gum, sugar-free mints, diet beverages, and some diabetic food products. The sugar-free chewing gum habit common among young urban Indians can deliver 10–15g of sorbitol daily from 5–6 sticks — sufficient to cause significant osmotic diarrhoea and bloating in IBS patients (and even in some healthy individuals). Xylitol (INS 967): Another sugar alcohol, similarly poorly absorbed. Less common in Indian packaged foods but present in some sugar-free products. Maltitol and other 'itol' sweeteners: Common in 'sugar-free' Indian sweets and diabetic chocolates — high FODMAP and poorly tolerated by IBS patients.

For IBS patients following a low-FODMAP approach, the most practical rule for packaged foods is: avoid products ending in '-ol' in the sweetener ingredient list (sorbitol, mannitol, xylitol, maltitol, lactitol, isomalt). The AaharIQ scanner specifically flags sugar alcohol content in the IBS safety assessment mode.

For Crohn's disease and ulcerative colitis patients, the diet considerations go beyond FODMAP — they involve managing the inflammatory component of IBD. Key packaged food considerations:

Avoid during flares: High-fibre packaged products (brown rice, whole grain cereals, nut-based products) — insoluble fibre irritates inflamed intestinal mucosa during active flares. During remission, gradual fibre reintroduction is beneficial. High-fat fried packaged snacks — fat stimulates colonic motility and can worsen diarrhoea during flares. Packaged dairy (for those with lactose sensitivity — common in both IBD and general Indian population). Packaged products with multiple emulsifiers and additives — the gut barrier disruption risk from emulsifiers is particularly relevant when IBD-related barrier function is already compromised. Alcohol-containing products (wine, certain flavour extracts, some packaged desserts). Relatively safer during remission: Plain packaged rice (low residue, gentle on gut). Plain packaged oats (soluble fibre — generally tolerated and beneficial for gut barrier repair). Packaged lean protein (eggs, plain canned fish without spices). Plain packaged probiotic yogurt — some IBD patients benefit from regular probiotic consumption; packaged live-culture curd (dahi) is an affordable Indian option. Packaged elemental nutrition formulas — specifically formulated for IBD, providing complete nutrition in an easily absorbed form that minimises gut mechanical load.